By cultivating collaborative partnerships with key stakeholders across the healthcare arena, including large wholesalers, group purchasing organizations (GPOs), buying groups, hospitals, pharmacies, payers, and patients, Kesin is working to solve challenges that interfere with therapy accessibility and adherence.
Our highly experienced leadership team and our capabilities in supply-chain management, pricing strategy, launch management, market access, warehouse and distribution, and private-label partnerships allow us to approach healthcare challenges in innovative and creative ways. The results are state-of-the-art products and operations with the power to fundamentally enhance patient care.
Narasimhan Mani, Ph.D., MBA, is a Healthcare professional with over 24 years of experience in the pharmaceutical industry. Prior to that, he served as the CEO of Xiromed LLC, a Generics and Specialty drug company. His previous roles include VP, Global Corporate Strategy and BD, at Amneal Pharmaceuticals, where he led strategic initiatives across the Generics, Specialty/Biosimilars, and Drug Discovery. His experiences include Corporate Finance and Strategic Planning roles at Johnson & Johnson. Dr. Mani received his Ph.D. in Pharmaceutics from the University of Georgia and an MBA from Columbia Business School, in New York, NY. He recently received the 2021 Outstanding 50 Asian Americans in Business Award.
Steven J. Esposito is a pharmaceutical sales professional with over 24 years of experience within the pharmaceutical industry. His previous experiences include roles at APP (now Fresenius-Kabi), AuroMedics (AuroBindo, USA), Sagent Pharmaceuticals, and Amneal Biosciences as a Sales Rep and National Account Director overseeing major GPOs, IDNs, and Distributors and implementing improved sales protocols for product placement and contracting. His most recent position was Vice President of Sales with Xiromed, LLC. Steven holds a Bachelor of Arts Degree from Northeastern Illinois University.
Jeffrey Sherman is an attorney with over 38 years of experience in the legal profession. He currently serves as General Counsel for Kesin Pharma, responsible for corporate governance, contracts and regulatory compliance matters. Mr. Sherman’s experience ranges from being a partner in private practice specializing in transactional work across financial services, real estate, automotive distribution and in the manufacturing and distribution of regulated products. Mr. Sherman received his undergraduate degree in Economics from Queens College, NY and his law degree from Stetson University College of Law, FL in 1984. He has been admitted to practice law in NY since 1984 and admitted in Florida since 1993.
Kevin Campbell is an accomplished pharmaceutical business leader experienced in directing strategic activities, expanding sustainable future growth, and bringing several decades of broad-based pharmaceutical sales and commercial operations experience with Generic, Brand, and Specialty Drugs. Leadership responsibility in Sales & Marketing, Sales/Commercial Operations, SCM & Quality Assurance. Experience: Corporate VP, Strategy & Development at FLAVORx; VP, Sales & Commercial Operations at Azurity Pharmaceuticals; Regional VP, Generic Sales at Par Pharmaceuticals, Inc.; Sr. Director, Operations Planning at Copley Pharmaceutical, Inc.; Supervisor, Quality Assurance at Fisons Pharmaceuticals.